What is the role of propranolol (propanolol) in the management of ethanol (ETOH) withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol is Not Recommended for Alcohol Withdrawal Management

Propranolol should not be used as a primary treatment for alcohol withdrawal as it may increase the risk of hallucinations and does not prevent seizures or delirium tremens. 1 Benzodiazepines remain the first-line medication for alcohol withdrawal management.

Evidence-Based Management of Alcohol Withdrawal

First-Line Treatment

  • Benzodiazepines are the gold standard treatment for alcohol withdrawal:
    • Diazepam is preferred for most patients with mild to moderate withdrawal symptoms due to its favorable pharmacokinetic profile 1, 2
    • Lorazepam (2-4 mg IV every 6-8 hours) may be preferred in patients with liver dysfunction 1

Monitoring and Assessment

  • Use the Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar) to guide treatment:
    • CIWA-Ar ≤7: Mild withdrawal - monitor, may not require medication
    • CIWA-Ar 8-14: Moderate withdrawal - initiate benzodiazepine treatment
    • CIWA-Ar ≥15: Severe withdrawal - aggressive benzodiazepine treatment, consider inpatient management 1

Why Propranolol is Contraindicated

  1. Increases hallucination risk - Beta-blockers like propranolol have been associated with increased risk of hallucinations during alcohol withdrawal 1
  2. Does not prevent seizures - Unlike benzodiazepines, propranolol does not protect against alcohol withdrawal seizures, a potentially life-threatening complication 3, 1
  3. Insufficient evidence - While some older studies suggested propranolol might help with certain symptoms like tremor 4, 5, current guidelines do not support its use as primary therapy

Appropriate Adjunctive Treatments

When benzodiazepines alone are insufficient, consider:

  1. Phenobarbital - May be used in combination with benzodiazepines for refractory cases 1, 2
  2. Propofol - Appropriate for patients refractory to benzodiazepines, particularly in ICU settings 2
  3. Gabapentin - May be considered as adjunctive therapy for post-acute withdrawal symptoms, particularly for insomnia, dysphoria, and craving 1

Nutritional Support

  • Thiamine supplementation (100-300 mg IV/IM) before any glucose-containing solutions is essential 1
  • Continue thiamine for 2-3 months 1
  • Consider B-complex vitamins, zinc, and vitamin D supplementation 1

Common Pitfalls to Avoid

  1. Using antipsychotics as monotherapy - These increase seizure risk and should only be used as adjuncts to benzodiazepines in severe withdrawal delirium that hasn't responded to adequate benzodiazepine doses 3, 1

  2. Inadequate benzodiazepine dosing - Protocolized escalation of benzodiazepines may be more effective than symptom-triggered approaches for severe withdrawal 2

  3. Overlooking nutritional deficiencies - All patients should receive thiamine supplementation to prevent Wernicke's encephalopathy 3, 1

  4. Failing to identify high-risk patients - Those with history of withdrawal seizures, severe withdrawal symptoms, or significant comorbidities require inpatient management 1

While some historical research suggested propranolol might help with certain withdrawal symptoms like tremor 4, 5, current guidelines clearly indicate that benzodiazepines are the cornerstone of alcohol withdrawal treatment, with propranolol specifically noted as potentially harmful due to its association with increased hallucination risk 1.

References

Guideline

Alcohol Withdrawal Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of Severe Alcohol Withdrawal.

The Annals of pharmacotherapy, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Propranolol in the treatment of alchoholism: a review.

Postgraduate medical journal, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.